Cullin 2 anticorps (Middle Region)

N° du produit ABIN3030577

Détail du produit anti-Cullin 2 anticorps

Antigène: Cullin 2 (CUL2)

Épitope: Middle Region

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Cullin 2 est non-conjugé

Application: Western Blotting (WB)

Purification: Antigen affinity

Immunogène: An amino acid sequence from the middle region of human Cullin-2 (HECQQRMVADHLQFLHA) was used as the immunogen for this CUL2 antibody.

Isotype: IgG

Information d'application

Indications d'application: The stated application concentrations are suggested starting amounts. Titration of the CUL2 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 0.5-1 μg/mL

Restrictions: For Research Use only

Stockage

Buffer: 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water

Stock: -20 °C

Stockage commentaire: After reconstitution, the CUL2 antibody can be stored for up to one month at 4°C. For long-term, aliquot and store at -20°C. Avoid repeated freezing and thawing.

Détails sur Cullin 2

Antigène: Cullin 2 (CUL2)

Autre désignation: CUL2 Cullin-2 (CUL2 Produits)

Synonymes: anticorps cul2, anticorps Cullin-2, anticorps fj48a06, anticorps wu:fj48a06, anticorps cullin-2, anticorps LOC100221330, anticorps 1300003D18Rik, anticorps 4932411N15Rik, anticorps AI327301, anticorps mKIAA4106, anticorps ATCUL2, anticorps F22D16.2, anticorps F22D16_2, anticorps cullin 2, anticorps cullin 2, anticorps cullin-2, anticorps putative cullin-2 (cul-2), anticorps cullin 2 L homeolog, anticorps Cullin-2, anticorps cul2, anticorps CUL2, anticorps PTRG_05231, anticorps Smp_079740, anticorps LOC100550749, anticorps Cul2, anticorps cul2.L, anticorps cul-2

Sujet: Cullin-2 is a protein that in humans is encoded by the CUL2 gene. Using immunofluorescence, it was shown that CUL2 is a cytosolic protein that can be translocated to the nucleus by VHL. By fluorescence in situ hybridization, Clifford et al.(1999) mapped the gene to 10p11.2-p11.1, a region reported to show loss of heterozygosity (LOH) in several forms of human cancer, including non-clear cell renal cell carcinoma. Pause et al.(1997) suggested that CUL2 is a candidate tumor suppressor gene, as has been proposed for CUL1 (603134). Lonergan et al.(1998) demonstrated that formation of the VBC-CUL2 complexes is linked to the regulation of hypoxia-inducible mRNAs by VHL. CUL2 is one of several proteins required for degradation of a class of RNA-binding germline proteins in somatic cells of the early blastomere.

UniProt: Q13617

Pathways: M Phase, Asymmetric Protein Localization, SARS-CoV-2 Protein Interactome